Kang-Xian Pills Inhibit Inflammatory Response and Decrease Gut Permeability to Treat Carbon Tetrachloride-Induced Chronic Hepatic Injury through Modulating Gut Microbiota
Kang-Xian (KX) pills have been clinically used for the treatment of chronic hepatic injury (CHI). However, the mechanisms of KX on CHI remain unknown. The aim of this study mainly focused on the anti-inflammatory effects of KX in a CHI mouse model based on modulating gut microbiota and gut permeabil...
Main Authors: | Li Wang, Huantian Cui, Yuting Li, Min Cao, Shanshan Man, Liying Guo, Jing Miao, Jianwei Jia, Yuhong Bian, Zhaiyi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/8890182 |
Similar Items
-
Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition
by: Xiaoyu Zhang, et al.
Published: (2018-08-01) -
Gut Microbiota and Intestinal Trans-Epithelial Permeability
by: Bénédicte Allam-Ndoul, et al.
Published: (2020-09-01) -
Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer
by: Lidia Sánchez-Alcoholado, et al.
Published: (2020-09-01) -
Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota
by: Cheng Wang, et al.
Published: (2021-09-01) -
Scutellarein Aggravated Carbon Tetrachloride-Induced Chronic Liver Injury in Gut Microbiota-Dysbiosis Mice
by: Zhimin Miao, et al.
Published: (2020-01-01)